Annex 1 & CCS remediation
Assess contamination-control gaps, strengthen CCS structure and connect identified risks with supporting controls, evidence and action plans.
Sterile manufacturing consulting from Pune, with remote support worldwide for contamination-control documentation, qualification evidence, cleanrooms, critical utilities and monitoring systems.

Engagements may begin during Annex 1 remediation, facility change, aseptic-process improvement, qualification activity or investigation of recurring environmental, utility or contamination-control concerns.
Assess contamination-control gaps, strengthen CCS structure and connect identified risks with supporting controls, evidence and action plans.
Support cleanroom, HVAC, personnel/material flow, utility and equipment readiness where sterile operations are being introduced or changed.
Strengthen APS/media-fill documentation, intervention rationale, execution readiness, deviation handling and supporting evidence.
Review monitoring, qualification and trend evidence where excursions, recurring events or control weaknesses require structured assessment.
Support is tailored to your site, system, product context, risk profile and internal quality procedures.
Sterile manufacturing control depends on the interaction between facility design, people, processes, utilities, environmental monitoring, qualification and operational discipline. These elements need to function as one integrated contamination-control system.
We support assessment, documentation and qualification activities that connect contamination risks to preventive controls, objective evidence and continued verification across the sterile-manufacturing lifecycle.
Support development and review of CCS elements, interfaces, supporting evidence and action tracking.
Gap assessment and readiness support against Annex 1 expectations for sterile operations and contamination control.
Qualification support for classification, airflow, HEPA integrity, pressure cascades, recovery and environmental conditions.
Protocol, report and evidence support for APS/media-fill design, execution, interventions, deviations and review.
Readiness and qualification support for sterilizers, depyrogenation tunnels, cycles, loads and critical parameters.
Review of EM strategy, locations, frequencies, limits, trends, investigations and linkage to contamination-control principles.
Review zoning, personnel and material flows, transfer controls and contamination risks across sterile areas.
Assessment and action tracking for critical sterile utilities, process gases and associated monitoring or control systems.
Annex 1 places contamination control at the centre of sterile manufacturing. Our approach connects risk assessment, facility and process controls, qualification, APS, monitoring and continued verification.
Identify contamination pathways, critical process steps, personnel and material interfaces, utilities, interventions and environmental risks.
Connect contamination risks with preventive and detective controls, responsibilities, supporting evidence and improvement actions.
Review cleanroom zoning, HVAC performance, pressure relationships, personnel/material movement and transfer controls.
Support qualification and evidence review for cleanrooms, HVAC, sterilisation systems, depyrogenation equipment and critical utilities.
Support APS/media-fill strategy, intervention assessment, execution documentation, deviations and evaluation of aseptic-process performance.
Use environmental, utility, process and qualification evidence to identify trends, investigate loss of control and support continued verification.
Deliverables are tailored to facility design, process risk, product, lifecycle stage, client procedures and applicable sterile-manufacturing requirements.
A sterile-manufacturing system in which contamination risks are understood, critical controls are supported by objective evidence and monitoring, qualification and operational practices remain connected through the CCS.
A remote review may cover the contamination-control strategy, facility information, relevant procedures, monitoring trends and qualification summaries supplied under the agreed scope. The review should identify questions that need direct observation or further evidence.
A document review has defined limits. Activities such as observing personnel practices, assessing interventions or reviewing physical airflow conditions may require suitable site-based assessment and evidence. The engagement should state those limits clearly.
Describe the product and presentation at a high level, whether processing is aseptic or terminally sterilised, the project stage and the main concern. Include the facility location and timeline so the remote and any on-site scope can be assessed.
Explore worldwide service coverageTell us your context and what outcome you need to achieve.
Work is scoped against applicable client procedures, regulatory requirements and guidance. Depending on the engagement, reference frameworks may include GxP, FDA 21 CFR requirements, EU GMP Annexes 1, 11 & 15, ICH Q9(R1), and ISO 9001:2015 quality-management principles.